Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2011-11-01 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHAMPIGNY-SUR-MARNE (94500), Val-de-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELURL PHARMACIE REPUBLIQUE 2000 is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHAMPIGNY-SUR-MARNE (94500),
this company of category PME
shows in 2022 a revenue of 2.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELURL PHARMACIE REPUBLIQUE 2000 (SIREN 535241095)
Indicator
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
2 160 192 €
N/C
N/C
N/C
Net income
104 626 €
259 628 €
261 640 €
142 813 €
130 404 €
111 372 €
EBITDA
N/C
N/C
285 944 €
N/C
N/C
N/C
Net margin
N/C
N/C
12.1%
N/C
N/C
N/C
Revenue and income statement
In 2024, SELURL PHARMACIE REPUBLIQUE 2000 generates positive net income of 105 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 111 k€ -> 105 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
104 626 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 1129%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 7%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
1128.608%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
6.669%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Debt ratio
988.354
842.522
770.134
414.712
446.968
1128.608
Financial autonomy
7.909
9.396
9.678
16.004
14.92
6.669
Repayment capacity
None
None
None
4.003
None
None
Cash flow / Revenue
None%
None%
None%
12.882%
None%
None%
Sector positioning
Debt ratio
1128.612024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of SELURL PHARMACIE REPUBLIQ... (1128.61) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
6.67%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of SELURL PHARMACIE REPUBLIQ... (6.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
4.0 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELURL PHARMACIE REPUBLIQ... (4.00) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 149.70. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
Liquidity ratio
154.067
188.006
163.218
184.167
176.453
149.696
Interest coverage
None
None
None
1.674
None
None
Sector positioning
Liquidity ratio
149.72024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Average-8 pts over 3 years
In 2024, the liquidity ratio of SELURL PHARMACIE REPUBLIQ... (149.70) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
1.67x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of SELURL PHARMACIE REPUBLIQ... (1.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 112 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 602 days. Excellent situation: suppliers finance 490 days of the operating cycle (retail model).
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
112 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
602 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELURL PHARMACIE REPUBLIQUE 2000
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
279 118 €
0 €
0 €
Inventory turnover (days)
0
0
0
46
0
0
Customer payment term (days)
0
0
0
7
0
112
Supplier payment term (days)
0
0
0
46
0
602
Positioning of SELURL PHARMACIE REPUBLIQUE 2000 in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELURL PHARMACIE REPUBLIQUE 2000 is estimated at
1 460 656 €
(range 1 017 177€ - 2 185 225€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1017k€1460k€2185k€
1 460 656 €Range: 1 017 177€ - 2 185 225€
NAF 5 année 2024
Valuation method used
Net Income Multiple
104 626 €
×
14.0x
=1 460 656 €
Range: 1 017 178€ - 2 185 225€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELURL PHARMACIE REPUBLIQUE 2000 with other companies in the same sector:
Frequently asked questions about SELURL PHARMACIE REPUBLIQUE 2000
What is the revenue of SELURL PHARMACIE REPUBLIQUE 2000 ?
The revenue of SELURL PHARMACIE REPUBLIQUE 2000 in 2022 is 2.2 M€.
Is SELURL PHARMACIE REPUBLIQUE 2000 profitable?
Yes, SELURL PHARMACIE REPUBLIQUE 2000 generated a net profit of 105 k€ in 2024.
Where is the headquarters of SELURL PHARMACIE REPUBLIQUE 2000 ?
The headquarters of SELURL PHARMACIE REPUBLIQUE 2000 is located in CHAMPIGNY-SUR-MARNE (94500), in the department Val-de-Marne.
Where to find the tax return of SELURL PHARMACIE REPUBLIQUE 2000 ?
The tax return of SELURL PHARMACIE REPUBLIQUE 2000 is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELURL PHARMACIE REPUBLIQUE 2000 operate?
SELURL PHARMACIE REPUBLIQUE 2000 operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart